Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Risperdal Consta Long-Acting Injection
Company:  Johnson & Johnson Pharmaceutical Research
Application No.:  021346
Approval Date: 10/29/2003


Date created: June 152005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.